Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Journal of Rare Diseases (Berlin, Germany)|October 21, 2024
Finerenone and other future therapeutic options for Alport syndromeHelen Pearce, Holly MabillardClinical Science (London, England : 1979)|February 18, 2020
SGLT2 inhibitors - a potential treatment for Alport syndromeHolly Mabillard, John A SayerF1000Research|October 26, 2020
Electrolyte Disturbances in SARS-CoV-2 InfectionHolly Mabillard, John A SayerJournal of Rare Diseases (Berlin, Germany)|March 3, 2025
GLP-1 receptor agonists-another promising therapy for Alport syndrome?Jan Boeckhaus, Holly Mabillard, John A SayerNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 14, 2021
Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney diseaseHolly Mabillard, John A Sayer, Eric OlingerJournal of Rare Diseases (Berlin, Germany)|December 26, 2022
UMOD and you! Explaining a rare disease diagnosisHolly Mabillard, Eric Olinger, John A SayerKidney360|July 2, 2026
Anti-Glomerular Basement Membrane Nephritis Post-Renal Transplant in Alport Syndrome PatientsLucy Hong, Holly Mabillard, John A SayerJournal of Rare Diseases (Berlin, Germany)|May 15, 2024
Explaining Alport syndrome-lessons from the adult nephrology clinicHolly Mabillard, Rebecca Ryan, Nik Tzoumas, et al.Case Reports in Nephrology|November 29, 2017
Large Retroperitoneal Haemorrhage Following Cyst Rupture in a Patient with Autosomal Dominant Polycystic Kidney DiseaseHolly Mabillard, Shalabh Srivastava, Philip Haslam, et al.Pageof 3